Advertisement

U.S. markets open in 3 hours 20 minutes

S&P Futures
4,539.75
+3.25(+0.07%)
Dow Futures
35,554.00
-3.00(-0.01%)
Nasdaq Futures
15,372.75
+31.75(+0.21%)
Russell 2000 Futures
2,285.90
-2.90(-0.13%)
Crude Oil
84.41
+0.65(+0.78%)
Gold
1,800.70
+4.40(+0.24%)

Advertisement

WATCH

Yahoo Finance's 2021 All Markets Summit — The Path Forward

October 25 from 9:00 a.m to 5 p.m. ET

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

126.72+1.67 (+1.34%)

At close: 4:02PM EDT

126.62 -0.10 (-0.08%)
Pre-Market: 05:49AM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	125.05
Open	125.51
Bid	0.00 x 800
Ask	0.00 x 1200
Day's Range	124.88 - 126.84
52 Week Range	103.13 - 129.70
Volume	4,874,988
Avg. Volume	4,664,842

Market Cap	224.652B
Beta (5Y Monthly)	0.67
PE Ratio (TTM)	31.44
EPS (TTM)	4.03
Earnings Date	Oct 20, 2021
Forward Dividend & Yield	1.80 (1.42%)
Ex-Dividend Date	Oct 14, 2021
1y Target Est	137.05

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-13% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABT

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Abbott Laboratories
Analyst Report: Abbott LaboratoriesAbbott Laboratories is a diversified healthcare company that develops, manufactures and markets a wide range of medical products and services. Its main product lines are nutritionals for adults and infants, diagnostic systems, vascular implants, cardiac rhythm management products, and diabetes care products.
Rating
Fair Value
Economic Moat
3 days agoArgus Research

All

News

Press Releases

Research Reports

Insider Monkey
10 Stocks Making Moves on Financial Results
In this article, we will take a look at the 10 stocks making moves on financial results. You can skip our detailed analysis of these companies, and go directly to the 5 Stocks Making Moves on Financial Results. Investors are closely watching the third-quarter earnings season, with several big-cap companies releasing their financial results. Tesla, […]
Motley Fool
3 Things Investors Should Love About Abbott's Q3 Results
Abbott Laboratories (NYSE: ABT) has given investors plenty to like through the years. Abbott provided its third-quarter update before the market opened on Wednesday. Here are three things that investors should love about the healthcare-giant's Q3 results.
SmarterAnalyst
Abbott Exceeds Q3 Expectations; Shares Jump 3.3%
Abbott Laboratories (ABT), a multinational medical devices and health care company, reported better-than-expected third-quarter results driven by solid COVID-19 related sales, new product approvals, and overall strong demand for all of its offerings. Following the news, shares jumped 3.3% to close at $123.31 on October 20. The company reported adjusted earnings of $1.40 per share, up 42.9% year-over-year, beating consensus estimates of $0.93 per share. Additionally, quarterly sales stood at $10.